Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience

MLA

Erica Quaquarini, et al. “Patterns of Treatment and Outcome with 500-Mg Fulvestrant in Postmenopausal Women with Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: A Real-Life Multicenter Italian Experience.” Therapeutic Advances in Medical Oncology, vol. 11, June 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....53ac5edcd2f19845b489e29201015c1d&authtype=sso&custid=ns315887.

APA

Erica Quaquarini, Pietro Lapidari, Cristina Teragni, Barbara Tagliaferri, Federico Sottotetti, Raffaella Palumbo, A. Ferzi, Francesco Serra, Antonio Bernardo, A. Gambaro, & Luca Licata. (2019). Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience. Therapeutic Advances in Medical Oncology, 11.

Chicago

Erica Quaquarini, Pietro Lapidari, Cristina Teragni, Barbara Tagliaferri, Federico Sottotetti, Raffaella Palumbo, A. Ferzi, et al. 2019. “Patterns of Treatment and Outcome with 500-Mg Fulvestrant in Postmenopausal Women with Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: A Real-Life Multicenter Italian Experience.” Therapeutic Advances in Medical Oncology 11 (June). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....53ac5edcd2f19845b489e29201015c1d&authtype=sso&custid=ns315887.